Impact of a Graduated Approach on Opioid Initiation and Loss of Earnings Following Workplace Injury: A Time Series Analysis.

J Occup Environ Med

The Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada (Drs Juurlink, Gomes, Ms Singh, Ms Martins); Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada (Dr Gomes); Workplace Safety and Insurance Board, Toronto, Ontario, Canada (Mr Theriault, Mr Duesburry, Dr Bain); Institute for Health Policy, Management, and Evaluation at the University of Toronto, Toronto, Ontario, Canada (Drs Juurlink, Gomes); and the Leslie Dan Faculty of Pharmacy at the University of Toronto, Toronto, Ontario, Canada (Dr Gomes).

Published: December 2017

Objective: The aim of this study was to explore the impact of the Ontario Workplace Safety and Insurance Board's (WSIB's) graduated approach to opioid management on opioid prescribing and disability claim duration.

Methods: We studied patterns of opioid use and disability claim duration among Ontarians who received benefits through the WSIB between 2002 and 2013. We used interventional time series analysis to assess the impact of the WSIB graduated formulary on these trends.

Results: After the introduction of the graduated formulary, initiation of short- and long-acting opioids fell significantly (P < 0.0001). We also observed a shift toward the use of short-acting opioids alone (P < 0.0001). Although disability claim duration declined, this could not be ascribed to the intervention (P = 0.18).

Conclusion: A graduated opioid formulary may be an effective tool for providers to promote more appropriate opioid prescribing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732644PMC
http://dx.doi.org/10.1097/JOM.0000000000001187DOI Listing

Publication Analysis

Top Keywords

graduated approach
8
approach opioid
8
time series
8
series analysis
8
disability claim
8
graduated formulary
8
impact graduated
4
opioid
4
opioid initiation
4
initiation loss
4

Similar Publications

Cellular and gene therapy (CGT) products have emerged as a popular approach in regenerative medicine, showing promise in treating various pancreatic and liver diseases in numerous clinical trials. Before these therapies can be tested in human clinical trials, it is essential to evaluate their safety and efficacy in relevant animal models. Such preclinical testing is often required to obtain regulatory approval for investigational new drugs.

View Article and Find Full Text PDF

Genetic landscape in undiagnosed patients with syndromic hearing loss revealed by whole exome sequencing and phenotype similarity search.

Hum Genet

January 2025

Division of Hearing and Balance Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-Ku, Tokyo, 152-8902, Japan.

There are hundreds of rare syndromic diseases involving hearing loss, many of which are not targeted for clinical genetic testing. We systematically explored the genetic causes of undiagnosed syndromic hearing loss using a combination of whole exome sequencing (WES) and a phenotype similarity search system called PubCaseFinder. Fifty-five families with syndromic hearing loss of unknown cause were analyzed using WES after prescreening of several deafness genes depending on patient clinical features.

View Article and Find Full Text PDF

Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer.

Sci Rep

January 2025

Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, 420 Delaware St SE, MMC 609, Minneapolis, MN, 55455, USA.

Within ovarian cancer research, patient-derived xenograft (PDX) models recapitulate histologic features and genomic aberrations found in original tumors. However, conflicting data from published studies have demonstrated significant transcriptional differences between PDXs and original tumors, challenging the fidelity of these models. We employed a quantitative mass spectrometry-based proteomic approach coupled with generation of patient-specific databases using RNA-seq data to investigate the proteogenomic landscape of serially-passaged PDX models established from two patients with distinct subtypes of ovarian cancer.

View Article and Find Full Text PDF

As one of their key regulatory ecosystem functions, inland lakes serve as CO sinks. The CO sink capacity of inland lakes depends on their water temperature and salinity as well as their water volume which are all highly sensitive to climate conditions. This paper aims to quantitatively estimate the change in the CO sink capacity of Wadi El-Rayan Lakes under climate change scenarios.

View Article and Find Full Text PDF

Purpose: Bladder preservation therapy in combination with atezolizumab and radiation therapy (BPT-ART) trial, which was a multicenter, open-label, single-arm phase II study, showed a promisingly high interim clinical complete response (cCR) rate of 84.4% (38/45). In the present study, we aimed to identify potential tissue biomarkers for achieving cCR via BPT-ART.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!